Member Info for Kiwi_

Where for art thou?

Seller?

;)

Certainly did mate lol

Where oh where is seller?

;)

A lot of buys and no sells, could this be the seller finally cleared?

BLUE?

;)

No worries mate

Hello mate,

If support breaks at 4.75p we could be looking at sub 4p

I enjoy reading your quick summary every day, I hope you are well and banking a few quid off of it mate.

:)

Just seems strange for the price to react like this, MMs don't seem to be short of stock for the time being anyway.

Effectively $47 Million USD

Wassatt, SAV = If Carlsburgh did RNSs

;)

Locked in for 12 months mate then 9 month orderly exit. I would say some decent duel dil would have gone on that one, plus it has been done at Friday's closing price. My feeling is MOZ or Oman must be due any day to.

;)

It's SAV I reckon Babbler. If Carlsburgh did RNSs

;)

If Carlsburgh did RNSs

;)

Current study of NFX's NXP001

First dosing of NXP001 took place successfully on 20 March 2019 in a cross-over study that aims to measure the relative bioavailability of NXP001 compared to Merck's EMEND® in healthy subjects. Dosing will complete during April 2019 with results expected by end H1 2019.

Worth noting that sales of Merck's EMEND totaled $556m in Merck's 2017 results

hTTps://investors.merck.com/news/press-release-details/2018/Merck-Announces-Fourth-Quarter-and-Full-Year-2017-Financial-Results/default.aspx

CEO today conducted a VOX market interview from Shanghai.

Obviously there to discuss progress of NXP001 with its Chinese partner Newsummit Biopharma.

Also worth noting that Nuformix previously said it was in discussions with multiple parties regarding the marketing of the Rest of World rights for NXP001.

Should start to pick up here soon enough with all the work from the company

NT Only or premium to buy, must have some serious orders to fill

Furthermore this is only one of the assets ;)